This Is the Optimal Way to Nap, According to Sleep Experts (Links to an external site)

Woman sleeping in bed with her arms crossed over her face

“Napping is not inherently a bad idea,” as long as you’re able to do it right, says Yo-El S. Ju, MD, a sleep physician scientist and Barbara Burton and Reuben Morriss III professor of neurology at the Washington University School of Medicine. If you can’t beat the post-lunch slump, a quick nap might help you […]

WashU Medicine Neurology Designated GLUT1 Collaborative Care Center of Excellence

Liu Lin Thio

The GLUT1 Deficiency Foundation has designated WashU Medicine / St. Louis Children’s Hospital as a GLUT1 Collaborative Care Center of Excellence. This prestigious designation places WashU Medicine Neurology among only 25 such centers worldwide. GLUT1 deficiency is a rare genetic disorder affecting the movement of glucose across the blood-brain barrier, leading to various neurological challenges. […]

A Different Type of Dementia Is Changing What’s Known About Cognitive Decline (Links to an external site)

Doctors told Ray Hester he was in the beginning stages of Alzheimer’s, but a brain scan revealed he had LATE dementia. “There’s a certain amount of relief knowing that it’s not Alzheimer’s,” his wife, Sandy, said.

A recently recognized form of dementia is changing the understanding of cognitive decline, improving the ability to diagnose patients and underscoring the need for a wider array of treatments. Patients are increasingly being diagnosed with the condition, known as LATE, and guidelines advising doctors how to identify it were published this year. LATE is now estimated to […]

What if we can stop Alzheimer’s before it starts? (Links to an external site)

What if we could stop Alzheimer's before it starts?

Our focus is simple: stop Alzheimer’s before it starts. This disease steals the moments that make us who we are and the memories we share. That’s why we believe in attacking Alzheimer’s from every angle — because every breakthrough means more time, more hope and more moments together for families who can’t wait.

Now accepting applications for 2025 WashU Medicine Bold Pioneer Award!

Bold Pioneer Award

The goal of the $10,000 WashU Medicine Bold Pioneer Award is to recognize and encourage early career investigators who have demonstrated bold, pioneering research that is high-risk by virtue of being fundamentally different from standard approaches. The intent is to encourage scientific research investigators to challenge status quo approaches by developing fundamentally different methods, approaches, […]

WashU community joins neighbors in tornado recovery (Links to an external site)

WashU's Danforth Campus suffered moderate damage when a deadly tornado ripped through parts of St. Louis May 16, and the storm took down multiple large trees. But other neighborhoods suffered greatly. In the aftermath, the WashU community has quickly mobilized to help its neighbors. (Photo: Whitney Curtis/WashU)

The Danforth Campus at Washington University in St. Louis suffered moderate damage in the deadly tornado that devastated parts of St. Louis May 16, including damaged building roofs and concrete. Additionally, the storm took down multiple large trees that blocked roads and triggered widespread power and technology outages. But that pales in comparison to the loss throughout the […]

Anti-amyloid drug shows signs of preventing Alzheimer’s dementia (Links to an external site)

Randall J. Bateman, MD, the Charles F. and Joanne Knight Distinguished Professor of Neurology at WashU Medicine, is the study director of an international clinical trial that finds an anti-amyloid drug can delay the onset of cognitive decline if given many years before symptoms of Alzheimer's disease arise. The participants in the study had inherited genetic variants that lead to early-onset Alzheimer's disease, and among those who received the drug the longest – an average of eight years – the treatment lowered the risk of developing symptoms from essentially 100% to about 50%, according to a preliminary analysis of the data.

An experimental drug appears to reduce the risk of Alzheimer’s-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a study led by the Knight Family Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), which is based at Washington University School of Medicine in St. Louis. The […]

Living Well: Red dye ban (Links to an external site)

Benjamin Kay

In January, the FDA banned the use of Red Dye No. 3 in foods and drugs because high concentrations of the dye were shown to cause cancer in rats. In this Living Well, First Alert 4’s Taylor Holt sits down with a local doctor to dig into the ban, find out what’s next and what […]

Generous donation from Jansky/Bander Family to fund Movement Disorders fellowships, support brain bank

Generous donation funds Movement Disorders fellowships, supports brain bank

The Jansky/Bander Family Fund, a generous commitment of $1,100,000 over five years, has been established to advance critical initiatives within the Section of Movement Disorders at Washington University School of Medicine in St. Louis Department of Neurology. This significant financial contribution is earmarked for two primary functions under the direction of Joel Perlmutter, MD: funding […]